Odyssey Health, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
OQB
Odyssey Health, Inc., a 10% owner and director of Oragenics Inc. (OGEN), has reported the complete sale of its common stock holdings in the company across two transactions in June 2025.
OQB
Odyssey Health, Inc., a 10% owner and director of Oragenics Inc. (OGEN), reported the sale of 10,000 shares of common stock across two transactions in mid-June 2025.
OQB
Christine Farrell, CFO of Odyssey Health, Inc., reports the acquisition of stock options.
OQB
Director Ricky Richardson acquired stock options for 300,000 shares of Odyssey Health, Inc. on June 28, 2024.
OQB
Director Jerome H. Casey acquired stock options for 300,000 shares of Odyssey Health, Inc.
OQB
Odyssey Health's CEO, J Michael Redmond, was granted stock options to purchase 500,000 shares of common stock on June 28, 2024.
OQB
Gregory Gironda, Chief Operating Officer of Odyssey Health, Inc., was granted stock options to purchase 250,000 shares of common stock.